A Fundamental Change in Asthma Management! Treatment of Moderate to Severe Asthma Now Includes Combined ICS-LABA Therapy as Maintenance and Rescue Therapy - Frankly Speaking EP 210Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato

This session will review the evidence used by the National Asthma Education and Prevention Program (NAEPP) in making their newer recommendations and the new asthma management protocols.

Begin

Already listened on another platform?

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 2/8/2021

Expiration Date: 2/8/2022

Topics

Learning Objectives

Explain the changes in managing asthma as proposed by the National Heart, Lung Blood Institute’s (NHLBI) National Asthma Education and Prevention Program (NAEPP).
Consider the role of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) in patients with moderate to severe asthma.
Recommend albuterol as a first line rescue intervention for children aged 6-11.

Faculty

Frank J. Domino, MD

Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA

Learn More

Robert A. Baldor, MD, FAAFP

Professor and Chairman, Dept of Family Medicine
UMass Medical School/Baystate

Learn More

Supported by

Not Applicable

Education Partner

Not Applicable